Multiple Sclerosis Treatment Center of Dallas
Dallas, Texas, United States
Medical clinic in Dallas, Texas
5303 Harry Hines Blvd 8th Floor, Dallas, TX 75390
About Multiple Sclerosis Treatment Center of Dallas
"We focus on the whole patient at the Multiple Sclerosis and Neuroimmunology Clinic at UT Southwestern Medical Center. Our multidisciplinary team cares for patients with multiple sclerosis, transverse myelitis, neuromyelitis optica, optic neuritis, acute disseminated encephalomyelitis, and autoimmune encephalitis."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Multiple Sclerosis Treatment Center of Dallas
During the past decade, Multiple Sclerosis Treatment Center of Dallas conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer
1998-04-01
2005-07-01
Completed
800
Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma
1997-09-01
Completed
96
Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer
1997-12-01
2009-03-01
Completed
45
Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer
1993-01-01
2006-08-01
Completed
398
High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma
1993-01-01
Unknown status
500
Combination Chemotherapy in Treating Men With Germ Cell Cancer
1998-10-01
Unknown status
498
Chemotherapy With or Without Surgery in Treating Patients With Stage II or Stage III Ovarian Cancer
1998-05-01
2001-01-01
Completed
1,000
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-05-01
2017-07-19
Completed
475
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Multiple Sclerosis Treatment Center of Dallas
According to Clinical.Site data, the most researched conditions in "Multiple Sclerosis Treatment Center of Dallas" are
"Neuromyelitis Optica" (2 trials) and "Neuromyelitis Optica Spectrum Disorder" (2 trials). Many other conditions were trialed in "Multiple Sclerosis Treatment Center of Dallas" in a lesser frequency.
Clinical Trials Intervention Types at Multiple Sclerosis Treatment Center of Dallas
Most popular intervention types in "Multiple Sclerosis Treatment Center of Dallas" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Eculizumab" (1 trials), "Placebo" (1 trials) and "eculizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Multiple Sclerosis Treatment Center of Dallas
The vast majority of trials in "Multiple Sclerosis Treatment Center of Dallas" are
2 trials for "All" genders.
Clinical Trials Status at Multiple Sclerosis Treatment Center of Dallas
Currently, there are NaN active trials in "Multiple Sclerosis Treatment Center of Dallas".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Multiple Sclerosis Treatment Center of Dallas,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Multiple Sclerosis Treatment Center of Dallas, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".